Eli Lilly & Co. (LLY) Tops Q3 EPS by 30c; Trims Outlook
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,107.08 --0%
Revenue Growth %: +31.7%
Financial Fact:
Dividends paid per share: 0.51
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +31.7%
Financial Fact:
Dividends paid per share: 0.51
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $0.10, $0.30 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $9.5 billion versus the consensus estimate of $8.97 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2023 EPS of $6.50-$6.70, versus the consensus of $6.72.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Lilly completes acquisition of Centessa Pharmaceuticals
- Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
